NAS:ARPO (USA) Also Trade In: Germany
Aerpio Pharmaceuticals Inc $ 1.34 0 (0%)
Warning! GuruFocus has detected 1 Medium warning sign with ARPO. Click here to check it out.
Avg Vol (1m):
Market Cap $:
Enterprise Value $:
Current and historical daily P/E ratio for ARPO (Aerpio Pharmaceuticals Inc) from 2017 to Oct 31 2020. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Aerpio Pharmaceuticals stock (ARPO) PE ratio as of Oct 31 2020 is 0. More Details
Aerpio Pharmaceuticals PE Ratio (TTM) Historical Data
View and export this data going back to 2017. Start your Free Trial
Aerpio Pharmaceuticals PE Ratio (TTM) Comparison
|Company||Market Cap(Mil)||PE Ratio (TTM)|
Compare NAS:NTRP NAS:ICCC AMEX:ANVS OTCPK:PKTX NAS:SBPH NAS:NOVN AMEX:AGE OTCPK:RGRX NAS:CRIS OTCPK:PMCB OCSE:NOVO B ASX:CSL NAS:VRTX NAS:REGN XKRX:207940 NAS:SGEN NAS:MRNA NAS:ALXN XKRX:068270 NAS:INCY
Address 9987 Carver Road, Cincinnati, OH, USA, 45242
Aerpio Pharmaceuticals Inc is a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases. The company's product AKB-9778, is a Tie2 activator being developed for the treatment of diabetic eye disease. Other products under the pipeline are cc-1536 and c-4924.